Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
4.130
+0.070 (1.72%)
At close: Sep 16, 2025, 4:00 PM EDT
4.130
0.00 (0.00%)
After-hours: Sep 16, 2025, 4:24 PM EDT
Relay Therapeutics Market Cap
Relay Therapeutics has a market cap or net worth of $712.06 million as of September 16, 2025. Its market cap has decreased by -22.13% in one year.
Market Cap
712.06M
Enterprise Value
89.47M
1-Year Change
-22.13%
Ranking
Category
Stock Price
$4.13
Market Cap Chart
Since July 16, 2020, Relay Therapeutics's market cap has decreased from $3.03B to $712.06M, a decrease of -76.54%. That is a compound annual growth rate of -24.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 699.99M | 1.50% |
| Dec 31, 2024 | 689.62M | -49.19% |
| Dec 29, 2023 | 1.36B | -24.86% |
| Dec 30, 2022 | 1.81B | -45.57% |
| Dec 31, 2021 | 3.32B | -11.11% |
| Dec 31, 2020 | 3.73B | 22.99% |
| Jul 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |